The latest report on the Drug of Abuse Testing Services market provides an in-depth analysis of the important aspects impacting the market growth, including drivers, constraints, risks, opportunities, and trends. The research study aids in the analysis of the industry in terms of individual growth patterns, prospects, and market contributions. This comprehensive research report includes a full market analysis and market expert's opinion from the standpoint of the current market position and future projections.
Get Sample Copy of Drug of Abuse Testing Services Market Report @ https://www.polarismarketresearch.com/industry-analysis/drugs-abuse-testing-services-market/request-for-sample
It includes a grant of USD 1.9 billion for the Substance Abuse and Mental Health Services Administration for funding of evidence-based prevention initiatives and services. Department of Defense also requested more than USD 1.2 billion to monitor and support drug interdiction to counter-drug operations on the U.S. soil.
Accessibility of the abuse testing services to the limited number of people with substance use across the market, with only being 1 in 7 cases being treated each year. However, in developed nations such as the U.S., there is a proper network and administration for reimbursement to treatment services to drug-related disorders. In line with this, the Centers for Medicare & Medicaid Services (CMS), in 2020, expanded its Medicare coverage to include medication-assisted treatment options in the opioid abuse testing and treatments scheduled.
COVID-19 Impact Analysis
With detailed research, the research report sheds light on the influence of the COVID-19 pandemic on the Drug of Abuse Testing Services market growth. This study will serve as a suitable roadmap for market players to design ways to overcome the negative effects of COVID-19 and take on the market's current prospects. The COVID-19 impact section of this research report is included to give market readers a comprehensive outlook of the market environment throughout the pandemic era and features estimates for the post-pandemic period.
Inquire Before Buying This Research Report @ https://www.polarismarketresearch.com/industry-analysis/drugs-abuse-testing-services-market/inquire-before-buying
Competitive Landscape of Drug of Abuse Testing Services Market
The research report includes authentic information on the market shares, production capacity, growth rates, product launches and future projects of the leading firms in the Drug of Abuse Testing Services industry. For conducting extensive analysis, the study used a balanced mix of primary and secondary research approaches. It addresses the critical market elements that must be considered during strategic planning for both existing and new competitors in the market. The prominent players operating in the market are:
Quest Diagnostics, United States Drug Testing Laboratories (USDTL), Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Clinical Reference Laboratory (CRL), Inc., Cordant Health Solutions, DrugScan, Omega Laboratories, Inc., Legacy Medical Services, Psychemedics Corporation, Mayo Clinic Laboratories, Precision Diagnostics, Millennium Health, American Substance Abuse Professionals (ASAP), Inc., and LGC Group.
Reasons to Purchase this Report
- Complete market analysis, including primary drivers, restraints, growth rate, current trends, and potential prospects.
- Company profiles featured in the report include essential financial information, SWOT analysis, product offering, current advances, and strategies adopted to make up the competitive landscape.
- Market segmentation study, which includes both quantitative and qualitative research, as well as the impact of policy and economic factors
- Domestic and country-level market analysis focusing on the demand and supply aspects that impact the Drug of Abuse Testing Services market's growth.
To Find More about COVID-19 Impact Analysis @ https://www.polarismarketresearch.com/industry-analysis/drugs-abuse-testing-services-market/inquire-before-buying
Drug of Abuse Testing Services, by Regional Outlook (Revenue – USD Million, 2016 – 2028)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Spain
- Netherlands
- Austria
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Central & South America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
About Polaris Market Research
Polaris Market Research is a Middle East market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: [email protected]
The global drugs of abuse testing market is expected to grow at a CAGR of 5.3% over the forecast period from 2016 to 2020, according to a new research report from Market Research Future (MRFR).
The global drug of abuse testing market is profiled in detail in the report, including an analysis of the market’s leading drivers and restraints, key players operating in the market, and the leading segments holding major shares in the market.
Increasing concern about drug usage among parents has led to an increasing demand for home kits that can be used by parents or other guardians to check whether their ward has consumed drugs.Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/1930 However, while drug of abuse testing equipment can indicate whether an individual has consumed the drug within a specific timeframe, they can’t reveal addiction patterns.
This is likely to be a key restraint against the global drugs of abuse testing market over the forecast period.Competitive Landscape:Several companies are impacting the global drug of abuse testing market.
These companies are Laboratory Corporation of America Holdings, Quest Diagnostics, Roche Holding Limited, Alere Inc., Randox Laboratories Ltd, Sonic Healthcare, Abbott Laboratories, Bio-Rad Laboratories, Inc, Thermo Fisher Scientific Inc., Psychemedics Corporation, and others.
The onsite screening test is gaining much prominence due to the implementation of stringent government technologies.
The latest report on the Greenhouse Film market provides an in-depth analysis of the important aspects impacting the market growth, including drivers, constraints, risks, opportunities, and trends.
The research study aids in the analysis of the industry in terms of individual growth patterns, prospects, and market contributions.
This comprehensive research report includes a full market analysis and market expert's opinion from the standpoint of the current market position and future projections.Get Sample Copy of Greenhouse Film Market Report @ https://www.polarismarketresearch.com/industry-analysis/greenhouse-film-market/request-for-sampleThe increase in the population worldwide and growth in global food demand majorly drives the market growth.
Growing urbanization, need to enhance agricultural yield, rising investments by government organizations on agricultural schemes, and increasing focus on nutritious food products and indoor farming accelerate the market growth.
New emerging markets, technological advancements in farming methods, growing demand and area used for greenhouse protected cultivation would provide growth opportunities in the market in the coming years.COVID-19 Impact AnalysisWith detailed research, the research report sheds light on the influence of the COVID-19 pandemic on the Greenhouse Film market growth.
This study will serve as a suitable roadmap for market players to design ways to overcome the negative effects of COVID-19 and take on the market's current prospects.
According to the new market research report “Esoteric Testing Market by Type (Infectious Disease, Endocrinology, Oncology, Toxicology, Immunology, Genetic Testing), Technology (MS, CLIA, ELISA, PCR), End User (Independent & Reference Laboratories, Hospital Laboratories) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period.Browse and in-depth TOC on “Esoteric Testing Market”134 – Tables47 – Figures244 – PagesDownload PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76794708Growth in the esoteric testing market is primarily driven by the rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis of cancer, and advancements in the personalized medicine are the major factors driving the growth of the esoteric testing market.The rising incidence of chronic and infectious diseases, increasing use of esoteric DNA sequencing technologies in precision medicine, early diagnosis of cancer, and advancements in the personalized medicine are the major factors driving the growth of the market.In 2020, infectious diseases accounted for the largest share of the Esoteric Testing Market.
In 2020, the infectious disease testing segment accounted the largest share of the Esoteric Testing Market.
The fastest growth of the genetic testing segment is attributed to the advancements in the sequencing technologies such as NGS and increasing awareness.CLIA segment account for the largest share of the market in 2020.Based on technology, Esoteric Testing Market is segmented into chemiluminescence immunoassay (CLIA), enzyme-linked immunosorbent assay (ELISA), mass spectrometry, real-time PCR, flow cytometry, DNA sequencing, and other technologies.
In addition, the ongoing automation, and digitalization of diagnostic laboratories, growing number of accredited laboratories, significant reimbursement coverage, and the competitive benefits offered by these providers are pushing the growth of the segment.Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76794708North America was the largest regional market for the Esoteric Testing Market in 2020The market is segmented into four major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America was the largest regional market for market in 2020.
Emerging APAC economies such as China and India are expected to see significant growth due their advancing healthcare infrastructure, increasing penetration of cutting-edge clinical laboratories, and expanding geriatric population are the major factors driving the growth of this market.The global Esoteric Testing Market is consolidated.
To know the trends and opportunities in Expression Vectors industry, Expression Vectors market research document is the best solution to go for.
This report presents broader perspective of the market place with its comprehensive market insights and analysis.
This business report provides all-inclusive knowledge and information of swiftly changing market landscape, what already subsists in the market, future trends or market expectations, the competitive environment, and competitor strategies that aids in planning business strategies and outshine the competitors.
The Expression Vectors report gives details about market analysis, market definition, market segmentation, key development areas,competitive analysis and research methodology.Global expression vectors market is set to witness a substantial CAGR of 6.3% in the forecast period of 2019-2026.
The report contains data of the base year 2018 and historic year 2017.
The rise in the market value can be attributed to increasing prevalence of infectious diseases, genetic disorders and other lifestyle associated diseases.This business report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market.
According to a research report "Cognitive Assessment and Training Market by Assessment Type (Pen- and Paper-Based, Hosted, Biometrics), Component, Application (Clinical Trial, Screening & Diagnostics, Brain Training, Academic Research), Vertical, and Region - Global Forecast to 2021", published by MarketsandMarkets, the cognitive assessment and training market size is expected to grow from USD 1.98 Billion in 2016 to USD 8.06 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 32.3%.Browse 63 market data tables and 47 figures spread through 150 pages and in-depth TOC on "Cognitive Assessment and Training Market - Global Forecast to 2021"The major forces driving this market are aging global population, increasing awareness about brain fitness, and advancements in technology.
The growing market for cognitive solutions and increasing demand for brain training by next-generation tech-savvy population are contributing to the growth of the cognitive assessment and training market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1039Clinical trials in terms of application is expected to hold the largest market share in the cognitive assessment and training market during the forecast periodClinical trials are mainly used to identify, measure, or monitor cognitive impairments and cognitive changes.
The assessment of cognitive functions is an integral part of decision-making during clinical drug development, as certain drugs can have an impact on the cognitive capabilities of the brain.
The market is expected to contribute the highest revenue for vendors offering clinical trials.Education vertical is expected to grow at the highest CAGR in the marketCognitive assessment solutions and services are used in the education vertical for screening prospective candidates for schools or colleges.
The leading cognitive assessment and training vendors for this vertical are Pearson Assessment and CogniFit.North America is expected to contribute to the largest market share and Asia-Pacific to grow at the highest CAGRNorth America is expected to hold the largest market share and to dominate the cognitive assessment and training market from 2016 to 2021, due to the increasing awareness among population about adopting medication for cognitive diseases.
The new generation in this region is more concerned toward the benefits of cognitive training, which is not just limited to patients with cognitive dysfunctions.
Growing global incidence of substance abuse, increasing cases of prescription diversion, and stringent laws mandating drug screening tests are key factors driving market growth Market Size – USD 1.25 Billion in 2020, Market Growth – at a CAGR of 6.6%, Market Trends – Increasing adoption of urine drug testing at workplaces The global specimen validity testing market size is expected to reach USD 2.10 Billion by 2028 at a CAGR of 6.6%, according to the latest report by Reports and Data.
Clinicians generally order SVT to make informed therapeutic decisions about medical conditions of their patients, which also includes therapeutic overuse and illicit drug abuse.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/4098Some Key Highlights From the Report:Reagents, calibrators, and controls segment is expected to account for largest revenue share among the products segment.
Growth can be attributed to increasing demand and repeated purchase of reagents due to rising number of specimens being tested in drug screening laboratories.Laboratory testing segment is expected to register robust revenue CAGR over the forecast period owing to increasing drug testing in established healthcare facilities, rising cases of drug abuse, and implementation of standardized specimen validity testing protocols in laboratories.Workplace segment is expected to register significant revenue growth over the forecast period owing to rising incidence of drug abuse at workplaces and increasing number of offices and organizations mandating workplace drug screening.North America is expected to account for largest revenue share between 2021 and 2028, attributable to growing use of illicit drugs, increasing incidence of prescription diversion, and presence of stringent laws mandating drug screening in countries in the region.
The key companies profiled in the market are: Thermo Fisher Scientific, Inc., Sciteck, American Bio Medica Corporation, Alere, Express Diagnostics, Premier Biotech, LabCorp., Quest Diagnostics, Alere Toxicology, ACM Global Laboratories, Clinical Reference Laboratory (CRL), SureHire, and CannAmm.For the purpose of this report, Reports and Data has segmented the global specimen validity testing market based on product & services, type, end-use, and region: Product & Services Outlook (Revenue, USD Billion; 2018-2028)ProductsReagents, Calibrators, & ControlsAssay KitsDisposableServicesType Outlook (Revenue, USD Billion; 2018-2028)Laboratory TestingRapid/POC TestingEnd-use Outlook (Revenue, USD Billion; 2018-2028) WorkplacesDrug Screening LaboratoriesLaw Enforcement AgenciesPain Management CentresDrug Rehabilitation CentresOthers Browse Complete Report “Specimen Validity Testing Market” @ https://www.reportsanddata.com/report-detail/specimen-validity-testing-marketThe report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region.
In-depth regional analysis covers: North AmericaU.S.CanadaMexicoEuropeGermanyU.K.FranceBENELUXRest of EuropeAsia PacificChinaJapanSouth KoreaRest of APACLatin AmericaBrazilRest of LATAMMiddle East & AfricaSaudi ArabiaA.E.Rest of MEAThe report includes primary and subjective research with a comprehensive study examined and validated by industry professionals and experts.
